Lawsuit Help Center Announces Full Dedication to Assisting Xarelto Victims

Share this news:

Lawsuitsettlementnews.com reports that two new court documents were issued in two courts, indicating that Xarelto lawsuit filings are growing against Bayer and Johnson & Johnson’s Janssen Pharmaceutical Division.

Los Angeles, CA – MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today that they are dedicated to helping victims, or their family members, who have suffered complications or even death as a result of using the blood thinner, Xarelto. This announcement comes just after new court documents were issued in two courts – the U.S. District Court in the Eastern District of Louisiana and the Philadelphia Court of Common Pleas in Pennsylvania. The two new court documents were issued in consolidated litigations over Xarelto in both states listed. Court documents dated March 23rd in the Philadelphia Court of Common Pleas show that approval came for a Master Long Form Complaint, indicating that plaintiffs with potential claims who want to file suit in that state will now be able to use the approved Master Long Form Complaint in Pennsylvania’s mass tort proceeding for Xarelto (In Re: Xarelto Litigation, Case ID 150102349). A court order dated March 24th in the U.S. District Court in the Eastern District of Louisiana – where the Xarelto federal multidistrict litigation (MDL) is underway – indicates that plaintiffs will now be able to file their cases directly in the proceedings (In Re: Xarelto Products Liability Litigation, No. 2592).


Currently, there are 402 filed lawsuits over Xarelto in the federal litigation in Louisiana, with an additional 204 known cases with similar claims pending in Pennsylvania’s mass tort proceeding, according to court documents. The lawsuits allege serious uncontrollable bleeding events and even death as a result of using the blood thinner, Xarelto. According to Drug Watch, lawsuits indicate that hundreds of patients have died as a result of bleeding events caused by Xarelto, and in 2012, the FDA reported that three times more people died while on the blood thinner, Xarelto, in comparison to warfarin due to adverse bleeding events. Now, the lawsuits are growing as the litigation picks up steam, and MTS is prepared to assist patients who believe they may have a potential claim against Xarelto’s maker, Bayer and Johnson & Johnson’s Janssen Pharmaceutical Division.


Patients or loved ones who are in need of some lawsuit guidance can apply for a free case evaluation by visiting: http://www.lawsuitsettlementnews.com/pradaxa-all-blood-thinner-cases


Plaintiffs who already have an attorney and have filed a lawsuit and need lawsuit money or a lawsuit funding cash advance, not to be confused with a lawsuit loan or pre-settlement loan, can contact Lawsuit Settlement News. Injured parties from Pradaxa or Xarelto usage and/or complications can apply for up to $50K in pre-settlement or settlement lawsuit funding. For a full list of the services that the company provides, visit: http://www.lawsuitsettlementnews.com/about-our-products-and-services


Victims, or their loved ones, who have been injured by Xarelto or Pradaxa and need lawsuit help, including finding an experienced Pradaxa or Xarelto law firm or applying for a cash advance on a Pradaxa or Xarelto lawsuit, can call toll-free to speak with a live agent at: 877.571.0405.


Plaintiffs may also fill out a quick application online at: www.lawsuitsettlementnews.com and an agent will respond shortly.


Disclaimer: MT Services LLC, operator of Lawsuitsettlementnews.com, is not a law firm and cannot provide legal advice on the plaintiff’s case; however, MTS works with lawyers involved in mass tort litigations who are willing to provide a free legal consultation at the consumer’s request. For a list of full disclosures, please visit the company’s website disclosure page.


Contact Info:
Name: Chris Janish
Email: info@masstortservice.com
Phone: 877.571.0405
Organization: Lawsuitsettlementnews.com


Source URL: http://www.prreach.com/pr/17442

Release ID: 81052

SUBSCRIBE FOR MORE